{"DataElement":{"publicId":"4972871","version":"1","preferredName":"Disease or Disorder Myeloid Type","preferredDefinition":"The disease type of hematopoietic (blood-forming) cells found in the bone marrow.","longName":"DsMyeloidTp","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"4972730","version":"1","preferredName":"Disease or Disorder Myeloid Classification","preferredDefinition":"Information related to the disease type of hematopoietic (blood-forming) cells found in the bone marrow.","longName":"2404658v1.0:4972728v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2404658","version":"1","preferredName":"Diseases and Disorders","preferredDefinition":"A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"005AD6E5-0651-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"PWEST","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"4972728","version":"1","preferredName":"Myeloid Classification","preferredDefinition":"Having to do with or resembling the bone marrow. May also refer to certain types of hematopoietic (blood-forming) cells found in the bone marrow. Sometimes used as a synonym for myelogenous; for example, acute myeloid leukemia and acute myelogenous leukemia are the same disease.:A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","longName":"C13349:C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myeloid","conceptCode":"C13349","definition":"A type of white blood cell. Neutrophils, eosinophils, and basophils are granulocytes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1D84635D-0A72-40FD-E050-BB89AD431ED9","latestVersionIndicator":"Yes","beginDate":"2015-08-17","endDate":null,"createdBy":"WONGW","dateCreated":"2015-08-17","modifiedBy":"ONEDATA","dateModified":"2015-08-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1D84635D-0A83-40FD-E050-BB89AD431ED9","latestVersionIndicator":"Yes","beginDate":"2015-08-17","endDate":null,"createdBy":"WONGW","dateCreated":"2015-08-17","modifiedBy":"MAESKEB","dateModified":"2019-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4972855","version":"1","preferredName":"Myeloid Disease or Disorder Type","preferredDefinition":"The disease type of hematopoietic (blood-forming) cells found in the bone marrow.","longName":"4972855v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Transient Myeloproliferative Disorder","valueDescription":"Transient Myeloproliferative Disorder of Down Syndrome","ValueMeaning":{"publicId":"4972857","version":"1","preferredName":"Transient Myeloproliferative Disorder of Down Syndrome","longName":"4972857v1.00","preferredDefinition":"A myeloid proliferation occurring in newborns with Down syndrome.  It is clinically and morphologically indistinguishable from acute myeloid leukemia and is associated with GATA1 mutations.  The blasts display morphologic and immunophenotypic features of megakaryocytic lineage.  In the majority of patients the myeloid proliferation undergoes spontaneous remission.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Transient Abnormal Myelopoiesis Associated with Down Syndrome","conceptCode":"C82339","definition":"A myeloid proliferation occurring in newborns with Down syndrome.  It is clinically and morphologically indistinguishable from acute myeloid leukemia and is associated with GATA1 mutations.  The blasts display morphologic and immunophenotypic features of megakaryocytic lineage.  In the majority of patients the myeloid proliferation undergoes spontaneous remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1D84E092-2B2A-1B8D-E050-BB89AD431767","latestVersionIndicator":"Yes","beginDate":"2015-08-17","endDate":null,"createdBy":"WONGW","dateCreated":"2015-08-17","modifiedBy":"KUMMEROA","dateModified":"2023-08-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1D84E092-2B43-1B8D-E050-BB89AD431767","beginDate":"2015-08-17","endDate":null,"createdBy":"WONGW","dateCreated":"2015-08-17","modifiedBy":"ONEDATA","dateModified":"2015-08-17","deletedIndicator":"No"},{"value":"Myelodysplastic Syndrome","valueDescription":"Myelodysplastic Syndrome","ValueMeaning":{"publicId":"3946618","version":"1","preferredName":"Myelodysplastic Syndrome","longName":"3946618","preferredDefinition":"A clonal hematopoietic disorder characterized by dysplasia and ineffective hematopoiesis in one or more of the hematopoietic cell lines. The dysplasia may be accompanied by an increase in myeloblasts, but the number is less than 20%, which, according to the WHO guidelines, is the requisite threshold for the diagnosis of acute myeloid leukemia. It may occur de novo or as a result of exposure to alkylating agents and/or radiotherapy. (WHO, 2001)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myelodysplastic Syndrome","conceptCode":"C3247","definition":"A clonal hematopoietic disorder characterized by dysplasia and ineffective hematopoiesis in one or more of the hematopoietic cell lines. The dysplasia may be accompanied by an increase in myeloblasts, but the number is less than 20%, which, according to the WHO guidelines, is the requisite threshold for the diagnosis of acute myeloid leukemia. It may occur de novo or as a result of exposure to alkylating agents and/or radiotherapy. (WHO, 2001)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"EA87B0E5-6712-6876-E040-BB89AD437204","latestVersionIndicator":"Yes","beginDate":"2013-11-06","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-11-06","modifiedBy":"GDEEN","dateModified":"2022-06-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1D84E092-2B57-1B8D-E050-BB89AD431767","beginDate":"2015-08-17","endDate":null,"createdBy":"WONGW","dateCreated":"2015-08-17","modifiedBy":"ONEDATA","dateModified":"2015-08-17","deletedIndicator":"No"},{"value":"Juvenile Myelomonocytic Leukemia","valueDescription":"Juvenile Myelomonocytic Leukemia","ValueMeaning":{"publicId":"2559013","version":"1","preferredName":"Juvenile Myelomonocytic Leukemia","longName":"2559013","preferredDefinition":"A myelodysplastic/myeloproliferative disease of childhood that is characterized by proliferation principally of the granulocytic and monocytic lineages.  Myelomonocytic proliferation is seen in the bone marrow and the blood.  The leukemic cells may infiltrate any tissue, however liver, spleen, lymph nodes, skin, and respiratory tract are the most common sites of involvement.  The prognosis is usually poor.  (WHO, 2001)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Juvenile Myelomonocytic Leukemia","conceptCode":"C9233","definition":"A clonal myeloid disorder of childhood previously classified as myelodysplastic/myeloproliferative neoplasm. It is characterized by the presence of monocytic proliferation in peripheral blood, less than 20% blasts in bone marrow and peripheral blood, splenomegaly, and the absence of BCR-ABL1 fusion. Almost all patients carry mutations of the RAS pathway.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B392-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1D84E092-2B61-1B8D-E050-BB89AD431767","beginDate":"2015-08-17","endDate":null,"createdBy":"WONGW","dateCreated":"2015-08-17","modifiedBy":"ONEDATA","dateModified":"2015-08-17","deletedIndicator":"No"},{"value":"Chronic Myelogenous Leukemia","valueDescription":"Chronic Myelogenous Leukemia","ValueMeaning":{"publicId":"4972859","version":"1","preferredName":"Chronic Myelogenous Leukemia","longName":"4972859","preferredDefinition":"Usually used to describe a condition that is persistent and long standing.: Referring to myelocytes, a type of white blood cell. Also called myeloid.: A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic","conceptCode":"C14141","definition":"Usually used to describe a condition that is persistent and long standing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Myelogenous","conceptCode":"C13394","definition":"Referring to myelocytes, a type of white blood cell. Also called myeloid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Leukemia","conceptCode":"C3161","definition":"A malignant (clonal) hematologic disorder, involving hematopoietic stem cells and characterized by the presence of primitive or atypical myeloid or lymphoid cells in the bone marrow and the blood. Leukemias are classified as acute or chronic based on the degree of cellular differentiation and the predominant cell type present. Leukemia is usually associated with anemia, fever, hemorrhagic episodes, and splenomegaly. Common leukemias include acute myeloid leukemia, chronic myelogenous leukemia, acute lymphoblastic or precursor lymphoblastic leukemia, and chronic lymphocytic leukemia. Treatment is vital to patient survival; untreated, the natural course of acute leukemias is normally measured in weeks or months, while that of chronic leukemias is more often measured in months or years.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1D84E092-2B70-1B8D-E050-BB89AD431767","latestVersionIndicator":"Yes","beginDate":"2015-08-17","endDate":null,"createdBy":"WONGW","dateCreated":"2015-08-17","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1D84E092-2B89-1B8D-E050-BB89AD431767","beginDate":"2015-08-17","endDate":null,"createdBy":"WONGW","dateCreated":"2015-08-17","modifiedBy":"ONEDATA","dateModified":"2015-08-17","deletedIndicator":"No"},{"value":"Acute Myeloid Leukemia","valueDescription":"Acute Myeloid Leukemia","ValueMeaning":{"publicId":"4263972","version":"1","preferredName":"Acute Myeloid Leukemia","longName":"4263972","preferredDefinition":"A clonal expansion of myeloid blasts in the bone marrow, blood or other tissues. The classification of acute myeloid leukemias (AMLs) encompasses four major categories: 1) AML with recurrent genetic abnormalities; 2) AML with multilineage dysplasia; 3) Therapy-related AML; 4) AML not otherwise categorized. The required bone marrow or peripheral blood blast percentage for the diagnosis of AML is 20% (WHO classification).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Myeloid Leukemia","conceptCode":"C3171","definition":"A clonal expansion of myeloid blasts in the bone marrow, blood or other tissues. The classification of acute myeloid leukemias (AMLs) encompasses four major categories: 1) AML with recurrent genetic abnormalities; 2) AML with multilineage dysplasia; 3) Therapy-related AML; 4) AML not otherwise specified. The required bone marrow or peripheral blood blast percentage for the diagnosis of AML is 20% (WHO classification).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F63DCAA0-1110-5D4B-E040-BB89AD432C9C","latestVersionIndicator":"Yes","beginDate":"2014-04-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-04","modifiedBy":"KUMMEROA","dateModified":"2022-05-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1D84E092-2B9D-1B8D-E050-BB89AD431767","beginDate":"2015-08-17","endDate":null,"createdBy":"WONGW","dateCreated":"2015-08-17","modifiedBy":"ONEDATA","dateModified":"2015-08-17","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4972854","version":"1","preferredName":"Myeloid Disease or Disorder Type","preferredDefinition":"Having to do with or resembling the bone marrow. May also refer to certain types of hematopoietic (blood-forming) cells found in the bone marrow. Sometimes used as a synonym for myelogenous; for example, acute myeloid leukemia and acute myelogenous leukemia are the same disease.:Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:Something distinguishable as an identifiable class based on common qualities.","longName":"C13349:C2991:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myeloid","conceptCode":"C13349","definition":"A type of white blood cell. Neutrophils, eosinophils, and basophils are granulocytes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1D84E092-2AFF-1B8D-E050-BB89AD431767","latestVersionIndicator":"Yes","beginDate":"2015-08-17","endDate":null,"createdBy":"WONGW","dateCreated":"2015-08-17","modifiedBy":"ONEDATA","dateModified":"2015-08-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1D84E092-2B10-1B8D-E050-BB89AD431767","latestVersionIndicator":"Yes","beginDate":"2015-08-17","endDate":null,"createdBy":"WONGW","dateCreated":"2015-08-17","modifiedBy":"KUMMEROA","dateModified":"2023-08-09","changeDescription":null,"administrativeNotes":"2023.8.9 Updated PV def for 'No Value Exists'. ak","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"3303197","version":"1","longName":"Phase 1/Pilot Consortium","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Myeloid disease type","type":"Preferred Question Text","description":"Myeloid disease type","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1D84E092-2BB7-1B8D-E050-BB89AD431767","latestVersionIndicator":"Yes","beginDate":"2015-08-17","endDate":null,"createdBy":"WONGW","dateCreated":"2015-08-17","modifiedBy":"WONGW","dateModified":"2015-08-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}